MER (mer proto-oncogene)
Showing 1 - 25 of 196
PD - Parkinson's Disease, Dexmedetomidine, Desflurane Trial in Beijing (general anesthesia, Conscious sedation)
Not yet recruiting
- PD - Parkinson's Disease
- +3 more
- general anesthesia
- Conscious sedation
-
Beijing, ChinaBeijing Tiantan Hospital, Capital Medical University
Oct 20, 2022
Complicated Intra-abdominal Infection, Hosptial Acquired Pneumonia, Ventilator Associated Pneumonia Trial in Worldwide (ATM-AVI,
Recruiting
- Complicated Intra-abdominal Infection
- +2 more
- ATM-AVI
- +3 more
-
Tucson, Arizona
- +152 more
Jan 20, 2023
Parkinson Disease Trial in France (Surgery under general anesthesia with experimental targeting, Usual Surgery)
Recruiting
- Parkinson Disease
- Surgery under general anesthesia with experimental targeting
- Usual Surgery
-
Amiens, France
- +9 more
May 31, 2022
BRAF V600E, Metastatic Colorectal Cancer Trial in China (Encorafenib, Cetuximab, FOLFIRI)
Recruiting
- BRAF V600E
- Metastatic Colorectal Cancer
- Encorafenib
- +2 more
-
Beijing, Beijing, China
- +33 more
Dec 20, 2022
PD - Parkinson's Disease Trial in Beijing (Dexmedetomidine)
Recruiting
- PD - Parkinson's Disease
-
Beijing, Beijing, ChinaBeijing Tiantan hospital
Jun 16, 2022
Mer-TK in Human Cardiac Cells
Completed
- Myocardial Inflammation
- Myocardial Infarction
- Change in Soluble MER Concentration
-
Chicago, IllinoisAnn & Robert H Lurie Children's Hopsital
Aug 10, 2021
Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma Trial in United States
Active, not recruiting
- Stage III Cutaneous Melanoma AJCC v7
- +2 more
- Computed Tomography
- +3 more
-
Birmingham, Alabama
- +759 more
Aug 18, 2022
Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))
Not yet recruiting
- Lung Cancer
- Non Small Cell Lung Cancer
- Amivantamab 1050mg
- +2 more
-
Aurora, Colorado
- +2 more
Apr 25, 2023
NSCLC Metastatic, Targetable Oncogenes (EGFR, ALK, ROS1) Trial in Boston (SBRT with protons or photons)
Active, not recruiting
- Non-small Cell Lung Cancer Metastatic
- Targetable Oncogenes (EGFR, ALK, ROS1)
- SBRT with protons or photons
-
Boston, MassachusettsMassachusetts General Hospital
Dec 22, 2021
MERTK Signalling in Monocytes/Macrophages in Liver Disease
Recruiting
- Liver Disease
- +3 more
- blood sampling for research purpose
- +3 more
-
Basel, Switzerland
- +3 more
Nov 17, 2021
Oropharynx Squamous Cell Carcinoma Trial (Blood sample)
Not yet recruiting
- Oropharynx Squamous Cell Carcinoma
- Blood sample
- (no location specified)
Jan 12, 2023
BRAF V600E Unresectable or Metastatic Melanoma, BRAF V600E Metastatic NSCLC, Melanoma Trial in Guangzhou (Encorafenib)
Completed
- BRAF V600E Unresectable or Metastatic Melanoma
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jun 9, 2022
Celiac Disease Trial in Ancona (Gluten (behaviour), Placebo (behaviour))
Completed
- Celiac Disease
- Gluten (behaviour)
- Placebo (behaviour)
-
Ancona, ItalyUniversity Department of Pediatrics
Mar 29, 2021
28 Day Mortality Trial (no intervention)
Recruiting
- 28 Day Mortality
- no intervention
-
Nanjing, Jiangsu, ChinaZhongda Hospital, Southeast University
Nov 25, 2022
Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer Trial (Q702, Pembrolizumab)
Not yet recruiting
- Esophageal Cancer
- +3 more
- Q702
- Pembrolizumab
- (no location specified)
Jun 27, 2022
Pancreatic Adenocarcinoma, Lung Cancer Trial in Truro (Biocartis Idylla platform - real time PCR detecting EGFR, KRAS and BRAF
Unknown status
- Pancreatic Adenocarcinoma
- Lung Cancer
- Biocartis Idylla platform - real time PCR detecting EGFR, KRAS and BRAF mutations in liquid based cytology and blood plasma samples
-
Truro, Cornwall, United KingdomRoyal Cornwall Hospital
Feb 26, 2021
Brain, Sedation Trial in Madison (Remifentanil, Propofol, Dexmedetomidine)
Terminated
- Brain
- Sedation
- Remifentanil
- +2 more
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Jun 17, 2022
Child Psychiatry Trial in Paris (The M.E.R. program)
Not yet recruiting
- Child Psychiatry
- The M.E.R. program
-
Paris, FranceHôpital Robert Debré
Dec 7, 2022
Non Small Cell Lung Cancer Metastatic Trial (MRI)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- MRI
- (no location specified)
May 16, 2023
Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)
Active, not recruiting
- Low-grade Glioma
- +2 more
-
Calgary, Alberta, Canada
- +6 more
Oct 25, 2022
Non Small Cell Lung Cancer Trial in Seoul (sotorasib)
Not yet recruiting
- Non Small Cell Lung Cancer
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jul 5, 2022
Anxiety Trial in Colmenar Viejo (Acceptance and Commitment Therapy (ACT), Mindfulness-based Emotional Regulation (MER))
Recruiting
- Anxiety
- Acceptance and Commitment Therapy (ACT)
- Mindfulness-based Emotional Regulation (MER)
-
Colmenar Viejo, Madrid, SpainCentro de Salud Mental de Colmenar Viejo Sur
Jan 24, 2022